These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 39121469)
1. Preferences and Willingness to Pay for Herpes Zoster Vaccination Among Chinese Adults: Discrete Choice Experiment. Xia Y; Wang M; Hu M; Wang Y; Yuan B; Zhu D; He P JMIR Public Health Surveill; 2024 Aug; 10():e51242. PubMed ID: 39121469 [TBL] [Abstract][Full Text] [Related]
2. Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster. Lieu TA; Ray GT; Ortega-Sanchez IR; Kleinman K; Rusinak D; Prosser LA Pharmacoeconomics; 2009; 27(12):1005-16. PubMed ID: 19908925 [TBL] [Abstract][Full Text] [Related]
3. Preferences for herpes zoster vaccination among adults aged 50 years and older in the United States: results from a discrete choice experiment. Patterson BJ; Myers K; Stewart A; Mange B; Hillson EM; Poulos C Expert Rev Vaccines; 2021 Jun; 20(6):729-741. PubMed ID: 33902368 [TBL] [Abstract][Full Text] [Related]
4. Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: A Discrete Choice Experiment. Marshall HS; Chen G; Clarke M; Ratcliffe J Vaccine; 2016 Jan; 34(5):671-677. PubMed ID: 26740249 [TBL] [Abstract][Full Text] [Related]
5. The effects of convenience and quality on the demand for vaccination: Results from a discrete choice experiment. Guo N; Zhang G; Zhu D; Wang J; Shi L Vaccine; 2017 May; 35(21):2848-2854. PubMed ID: 28410814 [TBL] [Abstract][Full Text] [Related]
6. Factors influencing herpes zoster vaccination among older people in China: results from a discrete choice experiment. Zhang H; Zhang LR; Chu LC; Sun X; Jiang XW Public Health; 2023 Jul; 220():33-34. PubMed ID: 37263175 [TBL] [Abstract][Full Text] [Related]
7. Potential cost-effectiveness of adjuvanted herpes zoster subunit vaccine for older adults in Hong Kong. You JHS; Ming WK; Lee CF; Tsang OT; Chan PK Vaccine; 2018 Jul; 36(31):4610-4620. PubMed ID: 29958739 [TBL] [Abstract][Full Text] [Related]
8. The epidemiologic and economic impact of varicella and herpes zoster vaccination in South Korea: A mathematical modelling study. Kim S; Choi JK; Suh J; Park SH; Lee J Vaccine; 2024 Jul; 42(19):4046-4055. PubMed ID: 38762358 [TBL] [Abstract][Full Text] [Related]
9. Attribute nonattendance in COVID-19 vaccine choice: A discrete choice experiment based on Chinese public preference. Xiao J; Wang F; Wang M; Ma Z Health Expect; 2022 Jun; 25(3):959-970. PubMed ID: 35049117 [TBL] [Abstract][Full Text] [Related]
10. A systematic review of the cost effectiveness of herpes zoster vaccination. Szucs TD; Pfeil AM Pharmacoeconomics; 2013 Feb; 31(2):125-36. PubMed ID: 23335045 [TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review. Chiyaka ET; Nghiem VT; Zhang L; Deshpande A; Mullen PD; Le P Pharmacoeconomics; 2019 Feb; 37(2):169-200. PubMed ID: 30367401 [TBL] [Abstract][Full Text] [Related]
12. Preferences heterogeneity of health care utilization of community residents in China: a stated preference discrete choice experiment. Jiang MZ; Fu Q; Xiong JY; Li XL; Jia EP; Peng YY; Shen X BMC Health Serv Res; 2020 May; 20(1):430. PubMed ID: 32423447 [TBL] [Abstract][Full Text] [Related]
13. Understanding influencing attributes of COVID-19 vaccine preference and willingness-to-pay among Chinese and American middle-aged and elderly adults: A discrete choice experiment and propensity score matching study. Li X; Yang L; Tian G; Feng B; Jia X; He Z; Liu T; Zhao X; Huang M; Yu W; Yu L; Ming WK Front Public Health; 2023; 11():1067218. PubMed ID: 37006586 [TBL] [Abstract][Full Text] [Related]
14. Mothers' Preferences and Willingness to Pay for Human Papillomavirus Vaccination for Their Daughters: A Discrete Choice Experiment in Hong Kong. Wong CKH; Man KKC; Ip P; Kwan M; McGhee SM Value Health; 2018 May; 21(5):622-629. PubMed ID: 29753361 [TBL] [Abstract][Full Text] [Related]
15. Treatment Preferences of Residents Assumed to Have Severe Chronic Diseases in China: A Discrete Choice Experiment. Lv Y; Fu Q; Shen X; Jia E; Li X; Peng Y; Yan J; Jiang M; Xiong J Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33203010 [TBL] [Abstract][Full Text] [Related]
16. Public preference for COVID-19 vaccines in China: A discrete choice experiment. Dong D; Xu RH; Wong EL; Hung CT; Feng D; Feng Z; Yeoh EK; Wong SY Health Expect; 2020 Dec; 23(6):1543-1578. PubMed ID: 33022806 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines. de Boer PT; van Lier A; de Melker H; van Wijck AJM; Wilschut JC; van Hoek AJ; Postma MJ BMC Med; 2018 Dec; 16(1):228. PubMed ID: 30518427 [TBL] [Abstract][Full Text] [Related]
18. Determinants of willingness to pay for self-paid vaccines in China. Hou Z; Jie Chang ; Yue D; Fang H; Meng Q; Zhang Y Vaccine; 2014 Jul; 32(35):4471-4477. PubMed ID: 24968160 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands. de Boer PT; Pouwels KB; Cox JM; Hak E; Wilschut JC; Postma MJ Vaccine; 2013 Feb; 31(9):1276-83. PubMed ID: 23306360 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults. Le P; Rothberg MB JAMA Intern Med; 2018 Feb; 178(2):248-258. PubMed ID: 29297049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]